Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $1.4100 (-14.55%) ($1.4100 - $1.4100) on Fri. Dec. 3, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.09% (three month average) | RSI | 38 | Latest Price | $1.4100(-14.55%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -3.6% a day on average for past five trading days. | Weekly Trend | ANPC declines -3.3% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) TIP(13%) GLD(10%) VIXM(10%) UNG(9%) UUP(9%) | Factors Impacting ANPC price | ANPC will decline at least -3.045% in a week (0% probabilities). IFRA(-20%) XLP(-19%) SDY(-19%) SPLV(-17%) VYM(-16%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.045% (StdDev 6.09%) | Hourly BBV | -2.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-31.15(-2309.22%) | Resistance Level | $1.83 | 5 Day Moving Average | $1.62(-12.96%) | 10 Day Moving Average | $1.66(-15.06%) | 20 Day Moving Average | $1.83(-22.95%) | To recent high | -59.5% | To recent low | 0% | Market Cap | $12m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |